|
Shavlovskaya O.A.
Musculoskeletal back pain: diagnostic algorithm, approaches to therapy
|
№4 / 2025
|
|
D.I. Trukhan, D.S. Ivanova
Role and location of increased epithelial permeability syndrome in the development of cardiovascular and bronchopulum diseases: theoretical and practical aspects of application of rebamipide
|
№5 / 2021
|
|
T.A. Sivokhina, M.V. Kozhina
EXPERIENCE OF THE USE OF CYTOPROTECTOR REBAMIPIDE IN THE TREATMENT OF NSAID-INDUCED EROSIVE GASTROPATHY
|
№18 / 2017
|
|
I.Z. Gaidukova, E.V. Khondkaryan, A.V. Aparkina, A.P. Rebrov
COMPARATIVE EFFICACY AND SAFETY OF THREE MODES FOR USE OF NONSTEROID ANTI-INFLAMMATORY DRUGS FOR THE TREATMENT OF CHRONIC BACK PAIN
|
№7 / 2017
|
|
E.N. Sukhikh, O.V. Simonova
CONCENTRATIONS OF STABLE METABOLITES OF NITRIC OXIDE IN THE SERUM AND URINE OF PATIENTS WITH ANKILOSING SPONDYLOARTHRITIS
|
№7 / 2017
|
|
V.V. Badokin
SUSTAGUARD ARTRO - NEW PREPARATION OF GLUCOSAMINE SULFATE FOR THE TREATMENT OF OSTEOARTHROSIS
|
№19 / 2016
|
|
N.V. Chichasova
OSTEOARTHROSIS AND COMORBIDITY: PROBLEM OF CHOICE OF NSAIDS
|
№19 / 2015
|
|
G.M. Kavalersky
DRUG ZEEL T IN THE TREATMENT OF DEGENERATIVE JOINT DISEASES (ANALYTICAL REVIEW)
|
№18 / 2014
|
|
Zh.A. Galeeva, S.K. Ziryanov, Yu.B. Belousov
PHARMACOTHERAPY OF INFLAMMATION AND PAIN: HOW TO MAKE THE OPTIMAL CHOICE?
|
№19 / 2013
|
|
V.V. Nikoda
LORNOXICAM: EFFICACY AND SAFETY OF ITS USE IN CLINICAL PRACTICE (LITERATURE REVIEW)
|
№13 / 2013
|
|
O.V. Kotova
SAFETY OF LONG-TERM USE OF NIMESULIDE (NISE)
|
№9 / 2013
|
|
S.G. Anikin, L.I. Alekseyeva
THE USE OF XEFOCAM (LORNOXICAM) IN PATIENTS WITH OSTEOARTHROSIS
|
№7 / 2013
|
Русский
